AtriCure reports solid 4Q revenue growth

Cardiac medical device maker AtriCure today announced preliminary financial results for fourth quarter and full year 2012.

Preliminary revenue for the fourth quarter of 2012 is expected to be approximately $18.4 million, about 9.5% more than fourth quarter 2011. Preliminary revenue for full year 2012 is expected to be $70.2 million, reflecting year-over-year growth of 9.1%.

West Chester-based AtriCure manufactures and markets cardiac surgical ablation systems designed to treat atrial fibrillation (AF) and systems for the exclusion of the left atrial appendage. The company brought on Mike Carrel as president and CEO AtriCure in November.

“In my first two months at AtriCure, I have spent considerable time evaluating the strategic and operational aspects of the company through in depth conversations with employees, clinical partners, customers, and shareholders,” Carrel said. “I have found many strengths—we have truly differentiated technology, solid customer relationships, an unparalleled training program, and a talented and committed group of employees.

Read AtriCure’s full news release here.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Alkermes announces initiation of phase 1 clinical study of ALKS 8700 for treatment of multiple sclerosis | Business Wire, July 17, 2014

National Psoriasis Foundation awards grants to two Case Western Reserve University researchers | Science Codex, July 16, 2014

HIV test developed at University Hospitals to be distributed nationally by Utah-based company | Cleveland.com, July 16, 2014

Chemoprevention and colon cancer: an interview with Dr. John Letterio, Case Western Reserve University School of Medicine | News Medical.net, July 16, 2014

Dayton Children’s Hosptial adds Dr. Aranda, bringing new advanced techniques in minimally invasive surgery | Xenia Gazette, July 16, 2014

3Bar Biologics takes cutting-edge technology out to corn fields | Akron Legal News, July 15, 2014

University of Cincinnati report shows need for better data on Ohio’s healthcare workforce | UC Health News, July 15, 2014

McNees recognized as one of the nation’s most-favored IP boutiques | McNees Wallace & Nurick, July 11, 2014

The Wright State University and Premier Health Neuroscience Institute has added Dayton Children’s to its research program | Dayton Business Journal, July 10, 2014

Sparton acquires Electronic Manufacturing Technology, LLC of Irvine, CA | Sparton, July 10, 2014

Cleveland Clinic collaborates Parker Hannifin to develop advanced medical technologies | PR Newswire, July 10, 2014

Austen BioInnovation Institute in Akron gets nearly $5 million in support | Akron Beacon Journal, July 9, 2014

Alkermes announces notices of allowance for U.S. patents for four CNS pipeline candidates | Business Wire, July 9, 2014

Students from Bethel-Tate High School gain valuable biotech job skills with Grant Career Center | WCPO9 Cincinnati, July 8, 2014

Rocket Ventures, the Regional Growth Partnership’s venture capital fund, is restarting its TechConnect networking events | Toledo Blade, July 8, 2014

NanoLogix news: Exhibiting at the Ohio Bioscience Expo and Showcase, receives European patent, working with NASA and Ohio Representative Tim Ryan | BusinessWire, July 8, 2014

CTI Clinical Trial and Consulting Services continues growth, adds seven and promotes three | Cincinnati.com, July 7, 2014

Sequentia rolls out discharge planner to help hospitals, patients navigate extended-care options | MedCity News, July 7, 2014

Cardinal Health continues to support future pharmacists with $2M in scholarships | PR Newswire, July 7, 2014

Case Western Reserve University awarded $12.6 million NIH grant for work on genetics of Alzheimer’s disease | Cleveland.com, July 7, 2014